Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04736589
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-02-03
First Post:
2021-01-31
Brief Title:
Inetetamab Plus Rapamycin and Chemotherapy for HER2 Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
Sponsor:
Peking Union Medical College
Organization:
Peking Union Medical College
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-02-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-31
First Submit QC Date:
January 31 2021
Study First Post Date:
2021-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-31
Last Update Post Date:
2021-02-03
Last Update Post Date Type:
ACTUAL